EP Patent

EP4273245A4 — Nucleic acid, pharmaceutical composition and sirna conjugate containing the nucleic acid, preparation method therefor, and use thereof

Assigned to Suzhou Ribo Life Science Co Ltd · Expires 2024-12-11 · 1y expired

What this patent protects

Patent listed against donidalorsen-sodium.

Drugs covered by this patent

donidalorsen-sodium (DONIDALORSEN SODIUM)

Patent Metadata

Patent number: EP4273245A4
Jurisdiction: EP
Classification: —
Expires: 2024-12-11
Drug substance claim: No
Drug product claim: No
Assignee: Suzhou Ribo Life Science Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.